332 related articles for article (PubMed ID: 9495222)
1. Pharmacokinetics of oral ganciclovir alone and in combination with zidovudine, didanosine, and probenecid in HIV-infected subjects.
Cimoch PJ; Lavelle J; Pollard R; Griffy KG; Wong R; Tarnowski TL; Casserella S; Jung D
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):227-34. PubMed ID: 9495222
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of oral ganciclovir capsules in HIV-infected persons.
Griffy KG
AIDS; 1996 Dec; 10 Suppl 4():S3-6. PubMed ID: 9110063
[TBL] [Abstract][Full Text] [Related]
3. Effect of high-dose oral ganciclovir on didanosine disposition in human immunodeficiency virus (HIV)-positive patients.
Jung D; Griffy K; Dorr A; Raschke R; Tarnowski TL; Hulse J; Kates RE
J Clin Pharmacol; 1998 Nov; 38(11):1057-62. PubMed ID: 9824788
[TBL] [Abstract][Full Text] [Related]
4. Phase I dose-escalation pharmacokinetics of AZT-P-ddI (IVX-E-59) in patients with human immunodeficiency virus.
Zhou XJ; Squires K; Pan-Zhou XR; Bernhard S; Agrofoglio L; Kirk M; Duchin KL; Sommadossi JP
J Clin Pharmacol; 1997 Mar; 37(3):201-13. PubMed ID: 9089422
[TBL] [Abstract][Full Text] [Related]
5. The safety profile and antiviral activity of the combination of stavudine, didanosine, and nelfinavir in patients with HIV infection.
Elion R; Kaul S; Knupp C; Adler M; Cross AP; Dunkle LM; Kelleher T
Clin Ther; 1999 Nov; 21(11):1853-63. PubMed ID: 10890257
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life.
Kovacs A; Cowles MK; Britto P; Capparelli E; Fowler MG; Moye J; McIntosh K; Rathore MH; Pitt J; Husson RN
Pediatr Infect Dis J; 2005 Jun; 24(6):503-9. PubMed ID: 15933559
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in children with HIV infection.
Gibb D; Barry M; Ormesher S; Nokes L; Seefried M; Giaquinto C; Back D
Br J Clin Pharmacol; 1995 May; 39(5):527-30. PubMed ID: 7669489
[TBL] [Abstract][Full Text] [Related]
8. Drug interactions with antiviral drugs.
Taburet AM; Singlas E
Clin Pharmacokinet; 1996 May; 30(5):385-401. PubMed ID: 8743337
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine.
Chien SC; Chow AT; Rogge MC; Williams RR; Hendrix CW
Antimicrob Agents Chemother; 1997 Aug; 41(8):1765-9. PubMed ID: 9257757
[TBL] [Abstract][Full Text] [Related]
10. Ganciclovir antagonizes the anti-human immunodeficiency virus type 1 activity of zidovudine and didanosine in vitro.
Medina DJ; Hsiung GD; Mellors JW
Antimicrob Agents Chemother; 1992 May; 36(5):1127-30. PubMed ID: 1510405
[TBL] [Abstract][Full Text] [Related]
11. Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
Darbyshire J; Foulkes M; Peto R; Duncan W; Babiker A; Collins R; Hughes M; Peto T; Walker A
Cochrane Database Syst Rev; 2000; (3):CD002038. PubMed ID: 10908523
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
Periclou AP; Nandy P; Avramis VI
In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
[TBL] [Abstract][Full Text] [Related]
13. In vivo evidence for carrier-mediated efflux transport of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine across the blood-brain barrier via a probenecid-sensitive transport system.
Takasawa K; Terasaki T; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 1997 Apr; 281(1):369-75. PubMed ID: 9103519
[TBL] [Abstract][Full Text] [Related]
14. Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
Darbyshire J; Foulkes M; Peto R; Duncan W; Babiker A; Collins R; Hughes M; Peto T; Walker A
Cochrane Database Syst Rev; 2000; 2000(2):CD002038. PubMed ID: 10796851
[TBL] [Abstract][Full Text] [Related]
15. A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease. AIDS Clinical Trials Group 231 Protocol Team.
Japour AJ; Lertora JJ; Meehan PM; Erice A; Connor JD; Griffith BP; Clax PA; Holden-Wiltse J; Hussey S; Walesky M; Cooney E; Pollard R; Timpone J; McLaren C; Johanneson N; Wood K; Booth D; Bassiakos Y; Crumpacker CS
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Nov; 13(3):235-46. PubMed ID: 8898668
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics and safety profile of oral ganciclovir combined with zalcitabine or stavudine in asymptomatic HIV- and CMV-seropositive patients.
Jung D; AbdelHameed MH; Teitelbaum P; Dorr A; Griffy K
J Clin Pharmacol; 1999 May; 39(5):505-12. PubMed ID: 10234599
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic evaluation of drug interactions with anti-HIV drugs, II: Effect of 2',3'-dideoxyinosine (ddI) on zidovudine kinetics in monkeys.
Gallo JM; Finco TS; Swagler AR; Mehta MU; Viswanathan CT; Qian M
AIDS Res Hum Retroviruses; 1992 Feb; 8(2):277-83. PubMed ID: 1540413
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic interaction between ritonavir and didanosine when administered concurrently to HIV-infected patients.
Cato A; Qian J; Hsu A; Vomvouras S; Piergies AA; Leonard J; Granneman R
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):466-72. PubMed ID: 9715843
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of didanosine and ketoconazole after coadministration to patients seropositive for the human immunodeficiency virus.
Knupp CA; Brater DC; Relue J; Barbhaiya RH
J Clin Pharmacol; 1993 Oct; 33(10):912-7. PubMed ID: 8227460
[TBL] [Abstract][Full Text] [Related]
20. Studies of zidovudine in combination with didanosine and zalcitabine.
Jablonowski H
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
